>
Investors are hedging against corporate defaults at a record pace:
Physicists captured a crystal made only of electrons, forming a honeycomb pattern without atoms...
US Treasury Largest Debt Buyback
BlackRock TCP Capital's Loan Write-Downs Masked by Restructurings
DARPA O-Circuit program wants drones that can smell danger...
Practical Smell-O-Vision could soon be coming to a VR headset near you
ICYMI - RAI introduces its new prototype "Roadrunner," a 33 lb bipedal wheeled robot.
Pulsar Fusion Ignites Plasma in Nuclear Rocket Test
Details of the NASA Moonbase Plans Include a Fifteen Ton Lunar Rover
THIS is the Biggest Thing Since CGI
BACK TO THE MOON: Crewed Lunar Mission Artemis II Confirmed for Wednesday...
The Secret Spy Tech Inside Every Credit Card
Red light therapy boosts retinal health in early macular degeneration

The Department of Health and Human Services report, which is expected to be published this month, will raise "low folate levels and acetaminophen during pregnancy" as possible causes of autism, people familiar with the matter told the Wall Street Journal.
The review will also highlight folinic acid, known as leucovorin, as a possible therapy to ease autism symptoms in some patients, sources told the Journal.
Autism affected about one in 31 8-year-olds in the US in 2022, according to federal estimates.
Tylenol, manufactured by McNeil Consumer Healthcare, a Kenvue subsidiary, is one of the most widely used over-the-counter painkillers — including among pregnant women.
Its active ingredient, acetaminophen, has been studied for decades.
Some research has suggested risks to fetal development, but other studies found no such link.
"We are using gold-standard science to get to the bottom of America's unprecedented rise in autism rates," an HHS spokesperson told The Post Friday.
"Until we release the final report, any claims about its contents are nothing more than speculation."
The Post has sought comment from Kenvue.
Shares of Kenvue plummeted by 16% after the Journal initially published its story during the course of trading on Wall Street on Friday afternoon — though the stock recovered somewhat near the closing bell.
The American College of Obstetricians and Gynecologists continues to say Tylenol is safe for pregnant women, though it advises all expectant mothers to consult doctors before taking any medication.
Kennedy's report will review existing scientific literature, not a new clinical study, sources told the Journal.
Researchers have long cautioned that pinpointing autism's causes takes years of rigorous work, with genetic factors already proven to play a major role.
"Nothing is more important to us than the health and safety of the people who use our products," a Kenvue spokeswoman told the WSJ.
"We have continuously evaluated the science and continue to believe there is no causal link between acetaminophen use during pregnancy and autism."
The looming report could go beyond Tylenol, sources told the Journal, by listing other possible causes of autism and calling for more research.
It is not yet clear whether vaccines — the longtime target of Kennedy's skepticism — will be included.